Plunkett Research Online: Geron Corporation

GERON CORPORATION (GERN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a .....



Geron Corporation
Ticker: GERN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 473-7700
Fax: 650 473-7750
Address: 919 East Hillsdale Boulevard
Suite 250
Foster City, CA 94404 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Discovery & Development
Telomerase Technologies
Human Stem Cell Technologies
Biopharmaceuticals
Clinical Testing
Contacts Description
John ScarlettCEO/Chairman of the Board/Director/President
Olivia BloomCFO/Chief Accounting Officer/Executive VP, Divisional/Treasurer
See More
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a .....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Imetelstat
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: